SCM
Sio Capital Management Portfolio holdings
AUM
$249M
This Quarter Return
+35.36%
1 Year Return
+117.71%
3 Year Return
+238.99%
5 Year Return
+411.91%
10 Year Return
+912.87%
AUM
$323M
AUM Growth
+$323M
(+15%)
Cap. Flow
-$43.7M
Cap. Flow
% of AUM
-13.51%
Top 10 Holdings %
Top 10 Hldgs %
39.14%
Holding
98
New
27
Increased
15
Reduced
28
Closed
21
Top Buys
| 1 |
HRC
HILL-ROM HOLDINGS, INC.
HRC
|
$9.88M |
| 2 |
SPDR Gold Trust
GLD
|
$9.37M |
| 3 |
Cencora
COR
|
$8.53M |
| 4 |
RCM
R1 RCM Inc. Common Stock
RCM
|
$8.51M |
| 5 |
SOLY
Soliton, Inc.
SOLY
|
$7.98M |
Top Sells
| 1 |
Amgen
AMGN
|
$21.5M |
| 2 |
Envista
NVST
|
$12.8M |
| 3 |
IMAB
I-MAB
IMAB
|
$10.6M |
| 4 |
MEI Pharma
MEIP
|
$10M |
| 5 |
Boston Scientific
BSX
|
$9.96M |
Sector Composition
| 1 | Healthcare | 81.51% |
| 2 | Industrials | 2.63% |
| 3 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
RDUS
26
DELISTED
Radius Health, Inc.
RDUS
| $4.94M | 1.44% |
362,402
-25,000
| -6% | -$341K |
|
|
AFMD
27
DELISTED
Affimed
AFMD
| $4.31M | 1.26% |
933,150
-85,050
| -8% | -$392K |
|
|
CHAQ.U
28
DELISTED
Chardan Healthcare Acquisition 2 Corp. Units, each consisting of one share of Common Stock, and one
CHAQ.U
| $4.2M | 1.23% |
+400,000
| New | +$4.2M |
|
29
Ardelyx
ARDX
$1.57B
| $4.16M | 1.21% |
601,534
-20,000
| -3% | -$138K |
|
30
Larimar Therapeutics
LRMR
$337M
| $4.09M | 1.19% |
318,258
-2,013,906
| -86% | +$1.59M |
|
31
Quanterix
QTRX
$202M
| $4M | 1.17% |
145,907
-91,174
| -38% | -$2.5M |
|
|
32
Boston Scientific
BSX
$159B
| $3.93M | 1.15% |
112,036
-283,711
| -72% | -$9.96M |
|
33
Immunovant
IMVT
$2.91B
| $3.71M | 1.08% |
152,450
+38,317
| +34% | +$933K |
|
34
Biogen
BIIB
$20.8B
| $3.69M | 1.08% |
13,800
-28,138
| -67% | -$7.53M |
|
|
IMAB
35
I-MAB
IMAB
$380M
| $3.54M | 1.03% |
118,409
-354,266
| -75% | -$10.6M |
|
36
Esperion Therapeutics
ESPR
$490M
| $3.16M | 0.92% |
61,600
-19,000
| -24% | -$975K |
|
37
Leap Therapeutics
LPTX
$12M
| $3.14M | 0.92% |
1,501,998
+402,456
| +37% | +$841K |
|
|
VAPO
38
DELISTED
Vapotherm, Inc. Common Stock
VAPO
| $3.11M | 0.91% |
+75,953
| New | +$3.11M |
|
|
SYRS
39
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $2.91M | 0.85% |
272,902
-195,630
| -42% | -$2.09M |
|
|
VRAY
40
DELISTED
ViewRay, Inc.
VRAY
| $2.9M | 0.85% |
+1,294,790
| New | +$2.9M |
|
41
Actinium Pharmaceuticals
ATNM
$53.3M
| $2.86M | 0.84% |
+8,147,650
| New | +$2.86M |
|
|
ASLN
42
DELISTED
ASLAN Pharmaceuticals Limited American Depositary Shares
ASLN
| $2.75M | 0.8% |
1,376,954
+82,043
| +6% | +$164K |
|
43
Avalo Therapeutics
AVTX
$139M
| $2.6M | 0.76% |
+1,000,000
| New | +$2.6M |
|
|
LSACU
44
DELISTED
LifeSci Acquisition Corp. Unit 1 COM & 1 WT
LSACU
| $2.31M | 0.67% |
210,000
| – | – |
|
45
RadNet
RDNT
$5.46B
| $2.15M | 0.63% |
+135,254
| New | +$2.15M |
|
46
Spyre Therapeutics
SYRE
$1.02B
| $1.95M | 0.57% |
+211,104
| New | +$1.95M |
|
47
Inogen
INGN
$213M
| $1.92M | 0.56% |
+54,000
| New | +$1.92M |
|
48
Dyadic International
DYAI
$35.4M
| $1.81M | 0.53% |
209,064
+29,269
| +16% | +$253K |
|
49
Vanda Pharmaceuticals
VNDA
$279M
| $1.65M | 0.48% |
144,114
-577,079
| -80% | -$6.6M |
|
|
NBSE
50
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
| $1.58M | 0.46% |
+179,404
| New | +$1.58M |
|